SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 25 Mar · 13:07 IST

Sanofi India Limited has informed the Exchange regarding 'Intimation of Book CLosure Dates'.

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹3248.00
prior close
₹3320.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.5+0.0-2.7-1.3-0.1+0.4+2.6+5.3+10.3+5.5-2.1+2.9
Up moveDown movePending
AI summary

Sanofi India's board met on March 25, 2026, and approved three key items. First, the 70th Annual General Meeting will be held on Wednesday, April 29, 2026, at 3:30 p.m. via video conferencing. Second, the company confirmed a final dividend of Rs. 48 per equity share (on shares of face value Rs. 10) for the financial year ended December 31, 2025, with the record date set as Wednesday, April 22, 2026, and share transfer books closed from April 23 to April 29, 2026. Third, the board appointed Mr. Siraj Azmat Chaudhry (DIN: 00161853) as an Additional Director and Independent Director for a 5-year term starting April 1, 2026, subject to shareholder approval at the AGM. Mr. Chaudhry is a former Chairman of Cargill India with over 35 years of experience in the agriculture and food industry, and currently serves on boards of Jubilant Ingrevia, Carrier India, Bikaji Foods, and Triveni Engineering.

Likely market impact

Shareholders holding Sanofi India shares as of April 22, 2026 (the record date) will be eligible for the Rs. 48 final dividend. The stock may see some activity around the ex-dividend/record date window. The new independent director brings strong FMCG and food sector leadership experience, which could add strategic value to the board.